Moreover, including the presence of necrosis as a parameter in ampullary carcinoma reports may facilitate the evaluation of potential HIF1α-targeting or antiangiogenesis therapies that can be used in these patients. The gene discussed is HIF1A; the disease is carcinoma of the ampulla of vater.